With regard to ALI alveolar fluid transport Talazoparib manufacturer can be up- or down-regulated [45]. Hypoxia inhibits transepithelial sodium transport in ex-vivo lungs [16], while endotoxin A from
Pseudomonas aeruginosa stimulates alveolar fluid clearance in rats [46], probably by cytokine-induced stimulation of sodium uptake. Conversely, intratracheal application of endotoxin-impaired alveolar fluid clearance in adult rats at 6 h of injury [26,47]. Evidence from previous studies indicates that a complex network of inflammatory cytokines and chemokines mediate and modify the inflammatory process in lung injury, including oedema formation [48–50]. It is known that inflammation in AEC is mitigated by application of sevoflurane [25]. Our in-vitro investigations in AECII reveal that LPS-induced impairment of both ENaC and Na+/K+-ATPase is reversed upon co-exposure to sevoflurane. These data suggest that active sodium transport and thus water transport can be increased functionally in injured AECII by administration of sevoflurane. So far, only type II cells were considered as the important regulators for salt and water buy LDK378 transport
[51]. However, as both types I and II AEC cells express sodium transport channels [52,53], AECI might also play an important role in water and salt homeostasis in the lung [52]. Therefore, after the positive findings in AECII, in-vitro experiments regarding sodium transport were reassessed in a mixture of types I and II cells, a set-up which more probably reflects the in-vivo situation with only 5% of type II and 95% of type I cells in the lungs. With this mixture of AEC (mAEC), no LPS-induced change or significant
influence of sevoflurane was observed for functionality of ENaC. For Na+/K+-ATPase we could demonstrate increased activity upon LPS exposure, while sevoflurane did not have any significant impact on its function. Therefore, we conclude that AECI are not involved actively in water reabsorption with regard to sodium channels. A previous study showed evidence that oxygenation improved significantly using sevoflurane in a post-conditioning set-up in an LPS-induced 4-Aminobutyrate aminotransferase ALI model (intratracheally applied LPS, followed 2 h later by application of sevoflurane compared to propofol anaesthesia) [26]. The present promising in-vitro results from AECII encouraged us to elucidate the question of to what extent sevoflurane may influence either oedema resolution or oedema formation. We were able to demonstrate that wet/dry ratio in the sevoflurane-treated animals was significantly lower compared to the propofol/LPS group, linking better oxygenation to less alveolar oedema. However, when blocking the activity of ENaC using amiloride, the wet/dry ratio remained unchanged.